ArticleIn Vivo and In Vitro Analysis of the Hedamycin (cas 11048-97-8) Polyketide Synthase

Add time:08/16/2019    Source:sciencedirect.com

SummaryHedamycin (cas 11048-97-8) is an antitumor polyketide antibiotic with unusual biosynthetic features. Earlier sequence analysis of the hedamycin biosynthetic gene cluster implied a role for type I and type II polyketide synthases (PKSs). We demonstrate that the hedamycin minimal PKS can synthesize a dodecaketide backbone. The ketosynthase (KS) subunit of this PKS has specificity for both type I and type II acyl carrier proteins (ACPs) with which it collaborates during chain initiation and chain elongation, respectively. The KS receives a C6 primer unit from the terminal ACP domain of HedU (a type I PKS protein) directly and subsequently interacts with the ACP domain of HedE (a type II PKS protein) during the process of chain elongation. HedE is a bifunctional protein with both ACP and aromatase activity. Its aromatase domain can modulate the chain length specificity of the minimal PKS. Chain length can also be influenced by HedA, the C-9 ketoreductase. While co-expression of the hedamycin minimal PKS and a chain-initiation module from the R1128 PKS yields an isobutyryl-primed decaketide, the orthologous PKS subunits from the hedamycin gene cluster itself are unable to prime the minimal PKS with a nonacetyl starter unit. Our findings provide new insights into the mechanism of chain initiation and elongation by type II PKSs.

We also recommend Trading Suppliers and Manufacturers of Hedamycin (cas 11048-97-8). Pls Click Website Link as below: cas 11048-97-8 suppliers

Prev:The divergent asymmetric synthesis of Kalafungin (cas 11048-15-0), 5-epi-frenolicin B and related pyranonaphthoquinone antibiotics
Next:ArticleThe Hedamycin (cas 11048-97-8) Locus Implicates a Novel Aromatic PKS Priming Mechanism)